Nitrostat 0.4 mg Sublingual Tablet
RxNorm 207346
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 207346 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Nitrostat 0.4 mg Sublingual Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Nitroglycerin 0.4 mg Sublingual Tablet [Nitrostat]
(Atom ID: 12355268)
PSNPrescribable
Prescribable Name (PSN):
Nitrostat 0.4 mg Sublingual Tablet
(Atom ID: 6358668)
SYPrescribable
Synonym (SY):
Nitrostat 0.4 mg Sublingual Tablet
(Atom ID: 1155848)
SYPrescribable
Synonym (SY):
NTG 0.4 mg Sublingual Tablet [Nitrostat]
(Atom ID: 3858412)
SYPrescribable
Synonym (SY):
TNG 0.4 mg Sublingual Tablet [Nitrostat]
(Atom ID: 3858411)
Patient Education
Nitroglycerin Sublingual
Nitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). It is also used just before activities that may cause episodes of angina in order to prevent the angina from occurring. Nitroglycerin is in a class of medications called vasodilators. It works by relaxing the blood vessels so the heart does not need to work as hard and therefore does not need as much oxygen.
[Learn More]
* Please review the disclaimer below.